Confocal NL.nl is thrilled to announce the successful completion of its latest funding round, securing €5 million to further advance the field of microscopy. This investment will significantly bolster our efforts to enhance the imaging experience for researchers globally by propelling our Re-scanning Confocal Microscopy (RCM) technology into the forefront of microscopy innovation. Our mission revolves around empowering scientists with the ability to upgrade their existing research microscopes to effectively utilize RCM technology, which is known for its capacity to deliver superior lateral resolution and unmatched sensitivity, all while preserving the essential sectioning ability of traditional confocal systems.
The funding will primarily be allocated towards research and development initiatives aimed at refining the RCM technology, ensuring that it remains not only innovative but also user-friendly and robust. This cutting-edge solution offers super-resolution imaging coupled with higher sensitivity compared to conventional photomultiplier tube (PMT)-based confocal microscopes. The advantages are particularly pronounced in live cell imaging scenarios, where minimizing phototoxicity and photobleaching is crucial for accurate and effective results.
At Confocal NL.nl, we pride ourselves on being curious, proactive, and customer-focused. We are driven by an immense passion for science, striving to create maximum value for our stakeholders. As we embark on this exciting journey, we look forward to collaborating with our partners and continuing to push the boundaries of microscopy, ultimately enhancing research capabilities across the globe.
